发明名称 |
LexA-based chemical-inducible gene expression system for use in transgenic animals |
摘要 |
The present invention relates generally to chemical-inducible system and to methods of use in transgenic animals. More specifically, the present invention relates to a chimeric transcription factor that binds to a ligand and functions in ligand-dependent manner to induce expression of genes of interest under the control of a synthetic operator-promoter sequence. The expression of genes of interest can be tightly controlled by adding or removing the ligand. |
申请公布号 |
US8852928(B2) |
申请公布日期 |
2014.10.07 |
申请号 |
US200812663323 |
申请日期 |
2008.07.02 |
申请人 |
Temasek Life Sciences Laboratory Limited |
发明人 |
Emelyanov Alexander;Parinov Sergey;Chua Nam-Hai |
分类号 |
C12N15/00;C07H21/02;C07H21/04;C12N15/85;A01K67/027;A01K67/00 |
主分类号 |
C12N15/00 |
代理机构 |
Rothwell, Figg, Ernst & Manbeck P.C. |
代理人 |
Rothwell, Figg, Ernst & Manbeck P.C. |
主权项 |
1. A system useful for preparing a non-human transgenic animal which comprises a first nucleic acid molecule comprising a first DNA construct and a second DNA construct, wherein:
(a) the first DNA construct encoding a chimeric transcription factor and having the following elements: (i) a DNA encoding a DNA binding domain of a bacterial LexA protein, (ii) a DNA encoding a truncated ligand binding domain of a human progesterone receptor and (iii) a DNA encoding an activation domain of the p65 subunit of human NF-κB, wherein the DNA of (i) comprises the nucleotide sequence set forth in SEQ ID NO:6 and the DNA of (ii) and (iii) comprises the nucleotide sequence set forth in SEQ ID NO:9; and wherein (b) the second DNA construct has the following elements in the 5′ to 3′ direction: (i) a operator comprising LexA binding sites, (ii) a promoter and (iii) a gene, wherein the operator comprises the nucleotide sequence set forth in SEQ ID NO:15. |
地址 |
Singapore SG |